Passage Bio, Inc. logo

Passage Bio, Inc.

PASG • NASDAQ

Passage Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William Chou, with a market cap of $35.9M.

Market Cap$35.9M
Employees85.0
CEOWilliam Chou
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
PAS

Passage Bio, Inc. FAQ

Common questions about Passage Bio, Inc.

Passage Bio, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.

Passage Bio, Inc. has approximately 85 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Passage Bio, Inc. (PASG) Q1 2026 Earnings - OpenCapital